Fresenius traded at 28.73 this Monday June 27th, increasing 0.63 or 2.24 percent since the previous trading session. Looking back, over the last four weeks, Fresenius gained 10.72 percent. Over the last 12 months, its price fell by 34.93 percent. Looking ahead, we forecast Fresenius to be priced at 27.10 by the end of this quarter and at 24.31 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
28.73
Daily Change
2.24%
Yearly
-34.93%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Akzo Nobel 65.48 1.00 1.55% -38.20%
Alcon AG 66.62 0.48 0.73% 3.13%
AstraZeneca 10,806.00 30.00 0.28% 24.69%
BASF 42.81 0.60 1.41% -34.44%
Bayer 59.40 1.61 2.79% 15.32%
Beiersdorf 98.62 0.64 0.65% -3.97%
DSM 142.75 5.00 3.63% -9.51%
DaVita Healthcare Partners 79.44 1.94 2.50% -34.79%
Essilor 143.30 -3.25 -2.22% -7.31%
E.ON 8.51 -0.09 -1.02% -14.30%
Fresenius Medical Care 47.69 0.60 1.27% -32.10%
Fresenius Medical Care 25.45 0.50 2.00% -39.16%
Fresenius 28.73 0.63 2.24% -34.93%
Getinge 236.20 5.80 2.52% -28.16%
Givaudan 3,298.00 -12.00 -0.36% -23.87%
GN Store Nord 243.70 -0.50 -0.20% -56.18%
GRIFOLS 19.16 0.63 3.37% -16.13%
GlaxoSmithKline 1,764.20 8.00 0.46% 24.13%
Hikma Pharmaceutical 1,666.00 29.00 1.77% -31.55%
Lonza Group 513.00 0.20 0.04% -23.04%
Merck 165.10 0.30 0.18% 3.45%
Novartis 82.04 1.44 1.79% -3.38%
Philips 20.85 0.24 1.16% -50.30%
Roche Holding 322.55 3.75 1.18% -7.33%
RWE 36.81 -0.61 -1.63% 19.44%
Sanofi 99.59 -0.97 -0.96% 11.76%
Smith & Nephew PLC 1,165.00 0 0% -25.20%
William Demant Holding 283.60 -5.20 -1.80% -20.74%

Indexes Price Day Year
DE40 13186 67.94 0.52% -15.22%
EU50 3539 5.71 0.16% -13.47%

Fresenius
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.